Jason Vitko

Title: Jason Vitko: Innovator in Biologics Production

Introduction

Jason Vitko is a notable inventor based in Bridgewater, NJ (US). He has made significant contributions to the field of biologics production, holding 2 patents that showcase his innovative approaches.

Latest Patents

One of Jason's latest patents is focused on the early post-transfection isolation of cells (EPIC) for biologics production. This patent provides methods for selecting a population of cells that express a target polypeptide. The disclosure includes techniques for sorting and selecting populations of transfected host cells based on their early expression of a selectable polypeptide. In certain embodiments, sorting is performed using fluorescence-activated cell sorting or magnetic-activated cell sorting based on the selectable polypeptide. These selection methods can be utilized to generate clonal populations of producer cells, which are essential for large-scale manufacturing of a target polypeptide of interest.

Career Highlights

Jason Vitko is currently employed at Genzyme Corporation, where he continues to advance his research and development efforts in the field of biologics. His work has been instrumental in enhancing the efficiency and effectiveness of biologics production processes.

Collaborations

Jason collaborates with esteemed colleagues such as Victor R Cairns and Christine T DeMaria. Their combined expertise contributes to the innovative environment at Genzyme Corporation.

Conclusion

Jason Vitko is a prominent figure in the field of biologics production, with a focus on innovative methods for cell selection and manufacturing. His contributions are paving the way for advancements in the industry.